Prevalence, Cost, and Variation in Cost of Pediatric Hospitalizations in Ontario, Canada.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
01 02 2022
01 02 2022
Historique:
entrez:
9
2
2022
pubmed:
10
2
2022
medline:
1
3
2022
Statut:
epublish
Résumé
Identifying conditions that could be prioritized for research based on health care system burden is important for developing a research agenda for the care of hospitalized children. However, existing prioritization studies are decades old or do not include data from both pediatric and general hospitals. To assess the prevalence, cost, and variation in cost of pediatric hospitalizations at all general and pediatric hospitals in Ontario, Canada, with the aim of identifying conditions that could be prioritized for future research. This population-based cross-sectional study used health administrative data from 165 general and pediatric hospitals in Ontario, Canada. Children younger than 18 years with an inpatient hospital encounter between April 1, 2014, and March 31, 2019, were included. Condition-specific prevalence, cost of pediatric hospitalizations, and condition-specific variation in cost per inpatient encounter across hospitals. Variation in cost was evaluated using (1) intraclass correlation coefficient (ICC) and (2) number of outlier hospitals. Costs were adjusted for inflation to 2018 US dollars. Overall, 627 314 inpatient hospital encounters (44.8% among children younger than 30 days and 53.0% among boys) at 165 hospitals (157 general and 8 pediatric) costing $3.3 billion were identified. A total of 408 003 hospitalizations (65.0%) and $1.4 billion (43.8%) in total costs occurred at general hospitals. Among the 50 most prevalent and 50 most costly conditions (of 68 total conditions), the top 10 highest-cost conditions accounted for 55.5% of all costs and 48.6% of all encounters. The conditions with highest prevalence and cost included low birth weight (86.2 per 1000 encounters; $676.3 million), preterm newborn (38.0 per 1000 encounters; $137.4 million), major depressive disorder (20.7 per 1000 encounters; $78.3 million), pneumonia (27.3 per 1000 encounters; $71.6 million), other perinatal conditions (68.0 per 1000 encounters; $65.8 million), bronchiolitis (25.4 per 1000 encounters; $54.6 million), and neonatal hyperbilirubinemia (47.9 per 1000 encounters; $46.7 million). The highest variation in cost per encounter among the most costly medical conditions was observed for 2 mental health conditions (other mental health disorders [ICC, 0.28] and anxiety disorders [ICC, 0.19]) and 3 newborn conditions (intrauterine hypoxia and birth asphyxia [ICC, 0.27], other perinatal conditions [ICC, 0.17], and surfactant deficiency disorder [ICC, 0.17]). This population-based cross-sectional study of hospitalized children identified several newborn and mental health conditions as having the highest prevalence, cost, and variation in cost across hospitals. Findings of this study can be used to develop a research agenda for the care of hospitalized children that includes general hospitals and to ultimately build a more substantial evidence base and improve patient outcomes.
Identifiants
pubmed: 35138399
pii: 2788854
doi: 10.1001/jamanetworkopen.2021.47447
pmc: PMC8829658
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2147447Commentaires et corrections
Type : CommentIn
Références
Arch Pediatr Adolesc Med. 2012 Dec;166(12):1155-64
pubmed: 23027409
Mater Sociomed. 2012;24(2):112-20
pubmed: 23678317
J Hosp Med. 2016 Nov;11(11):743-749
pubmed: 27373782
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
JAMA. 2018 Sep 11;320(10):995-1004
pubmed: 30208456
PLoS Med. 2008 Aug 12;5(8):e172
pubmed: 18700813
JAMA Netw Open. 2021 Jul 1;4(7):e2117816
pubmed: 34309667
Pediatr Pulmonol. 2011 May;46(5):452-7
pubmed: 21194139
Pediatrics. 2013 Aug;132(2):229-36
pubmed: 23878044
Health Aff (Millwood). 2014 May;33(5):815-22
pubmed: 24799579
Lancet. 2018 Dec 15;392(10164):2595-2605
pubmed: 30509743
J Clin Epidemiol. 2007 Feb;60(2):118-23
pubmed: 17208117
Trials. 2016 Nov 22;17(1):556
pubmed: 27876084
JAMA. 2011 Feb 16;305(7):682-90
pubmed: 21325184
Healthc Manage Forum. 2020 Nov;33(6):282-287
pubmed: 32613867
Health Rep. 1999 Autumn;11(2):9-19(Eng); 9-21(Fre)
pubmed: 10618739
Arch Dis Child Fetal Neonatal Ed. 1999 Jul;81(1):F1-4
pubmed: 10375353
Can J Public Health. 2012 Apr 30;103(8 Suppl 2):S12-6
pubmed: 23618065
J Paediatr Child Health. 2012 Jul;48(7):596-9
pubmed: 22409276
Children (Basel). 2020 Dec 15;7(12):
pubmed: 33333770
Health Aff (Millwood). 2011 Dec;30(12):2235-42
pubmed: 22147850
Child Care Health Dev. 2010 Jul;36(4):574-82
pubmed: 20337643
Can J Surg. 2016 Jun;59(3):161-6
pubmed: 27240284
Pediatrics. 2016 Feb;137(2):e20151829
pubmed: 26783324
Arch Pediatr Adolesc Med. 2010 Mar;164(3):283-8
pubmed: 20194264
J Hosp Med. 2017 Oct;12(10):818-825
pubmed: 28991947
JAMA Pediatr. 2017 Feb 6;171(2):e163926
pubmed: 27942727
JAMA Pediatr. 2021 May 1;175(5):525-527
pubmed: 33646300
BMC Pediatr. 2005 Sep 21;5:38
pubmed: 16176579
Pediatrics. 2019 May;143(5):
pubmed: 31018987